Synonym
SPI1865; SPI 1865; SPI-1865
IUPAC/Chemical Name
(2aR,4S,6aR,7aS,9aR,9bR,10R,12R,13aR,14R,14aS,14bR)-12-((S)-1-Ethoxy-2-hydroxy-2-methylpropyl)-4-(((S)-4-(1-isopropylazetidin-3-yl)morpholin-2-yl)oxy)-3,3,9a,10,14a-pentamethyloctadecahydro-7H-cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-14-ol
InChi Key
ITAXZEXGQGVKHD-QWBCZVDJSA-N
InChi Code
InChI=1S/C42H72N2O6/c1-11-47-36(38(7,8)46)28-20-26(4)33-34(49-28)35(45)40(10)30-13-12-29-37(5,6)31(14-15-41(29)24-42(30,41)17-16-39(33,40)9)50-32-23-43(18-19-48-32)27-21-44(22-27)25(2)3/h25-36,45-46H,11-24H2,1-10H3/t26-,28-,29+,30+,31+,32+,33+,34-,35+,36+,39-,40-,41-,42+/m1/s1
SMILES Code
O[C@@H]1[C@@]2(C)[C@@](CC[C@@]3([H])C(C)(C)[C@@H](O[C@H]4CN(C5CN(C(C)C)C5)CCO4)CC[C@@]36C7)([H])[C@@]67CC[C@]2(C)[C@]8([H])[C@@]1([H])O[C@@H]([C@H](OCC)C(C)(O)C)C[C@H]8C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
701.05
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Findeis MA, Schroeder FC, Creaser SP, McKee TD, Xia W. Natural Product and Natural Product-Derived Gamma Secretase Modulators from Actaea Racemosa Extracts. Medicines (Basel). 2015 Jun 30;2(3):127-140. doi: 10.3390/medicines2030127. Review. PubMed PMID: 28930205; PubMed Central PMCID: PMC5456218.
2: Hubbs JL, Fuller NO, Austin WF, Shen R, Ma J, Gong Z, Li J, McKee TD, Loureiro RM, Tate B, Dumin JA, Ives J, Bronk BS. Minimization of drug-drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1621-6. doi: 10.1016/j.bmcl.2015.01.051. Epub 2015 Feb 10. PubMed PMID: 25708617.
3: Loureiro RM, Dumin JA, McKee TD, Austin WF, Fuller NO, Hubbs JL, Shen R, Jonker J, Ives J, Bronk BS, Tate B. Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models. Alzheimers Res Ther. 2013 Apr 18;5(2):19. doi: 10.1186/alzrt173. eCollection 2013. PubMed PMID: 23597079; PubMed Central PMCID: PMC3707052.